 |
|
|
|
Common Anesthetic May Induce Cell Death, Generation Of Alzheimer's-associated ProteinScience Daily — A new study has found how one of the most commonly used anesthetics may produce Alzheimer's-like changes in the brain. Previous studies have shown that applying the anesthetic isoflurane to cultured neural cells can lead to generation of amyloid-beta protein -- the key component of senile plaques seen in the brains of Alzheimer's patients -- and to the cell-death process known as apoptosis. In the Feb. 7 Journal of Neuroscience, researchers from Massachusetts General Hospital (MGH) and colleagues describe how isoflurane may set off a process in which A-beta generation and apoptosis interact with and magnify each other. Since this work was done in cell cultures, it is unknown whether the findings reflect a possible effect of the anesthetic on human brains. "Our studies have shown that isoflurane may induce a vicious cycle of apoptosis, amyloid-beta generation, and further rounds of apoptosis leading to cell death," says Zhongcong Xie, MD, PhD, of the MassGeneral Institute for Neurodegenerative Disease (MGH-MIND), the study's lead author. "If future studies support these findings, they suggest that caution be used in choosing this anesthetic for elderly patients, who already are at increased risk for Alzheimer's and for postoperative cognitive dysfunction." Xie is also associated with the MGH Department of Anesthesia and Critical Care. Alzheimer's disease is characterized by plaques within the brain of amyloid-beta protein (A-beta), which is toxic to brain cells. A-beta is formed when the larger amyloid precursor protein (APP) is clipped by two enzymes -- beta-secretase, also known as BACE, and gamma-secretase -- to release the A-beta fragment. Normal processing of APP by an enzyme called alpha-secretase produces an alternative, non-toxic protein. Some studies have indicated that general anesthesia may increase the risk of developing Alzheimer's disease. It also is known that a small but significant number of surgical patients experience a form of dementia in the postoperative period, but there is insufficient evidence of a direct connection between anesthesia and the risk of dementia. Previous articles -- including a recent report from the same research team -- have shown that isoflurane increases both A-beta generation and apoptosis in several types of cultured cells. The current study was designed to investigate the relationship between isoflurane-induced apoptosis and A-beta generation. In a series of experiments, the researchers first found that applying isoflurane to cultured neural cells increased the activation of the enzyme caspase -- a key player in a pathway leading to apoptosis -- with no change in A-beta generation or APP processing. When they applied isoflurane to neural cells that express APP and had been treated with a caspase inhibitor, the expected changes in APP processing and A-beta generation were significantly reduced, indicating that caspase activation is essential to the pathway leading to A-beta generation and aggregation. The researchers also found that isoflurane appears to raise levels of the A-beta-releasing enzymes BACE and gamma secretase and that generation of A-beta plaques further increases isoflurane-induced caspase activation. In addition, adding A-beta to neuronal cells that do not express APP also increased caspase activation in response to isoflurane. Overall, the study's results define molecular pathways by which isoflurane induces deposition of A-beta, both directly and via caspase activation, and by which A-beta deposits lead to further caspase activation and apoptosis. "Even though our findings and those from other studies suggest that isoflurane may affect Alzheimer's pathogenesis, these experiments were performed in cultured cells only," says Rudolph Tanzi, PhD, director of the MGH-MIND Genetics and Aging Research Unit and senior author of the current paper. "We need to conduct in vivo studies before we can determine whether these results might be relevant to the development of delirium or Alzheimer's disease in human patients." Tanzi is a professor of Neurology at Harvard Medical School, where Xie is an assistant professor of Anesthesia. The researchers also plan to investigate whether other anesthetic agents may produce the same results seen with isoflurane, which is the only anesthetic tested in previous studies. Co-authors of the Journal of Neuroscience report are Yuanlin Dong and Uta Maeda, of MGH-MIND and MGH Anesthesia; Robert D. Moir, PhD, of MGH-MIND; and Weiming Xia, Deborah Culley, MD, and Gregory Crosby, MD, of Brigham and Women's Hospital. The study was supported by grants from the National Institutes of Health and the American Geriatrics Society. Massachusetts General Hospital, established in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of nearly $500 million and major research centers in AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, human genetics, medical imaging, neurodegenerative disorders, regenerative medicine, transplantation biology and photomedicine. MGH and Brigham and Women's Hospital are founding members of Partners HealthCare System, a Boston-based integrated health care delivery system. Note: This story has been adapted from a news release issued by Massachusetts General Hospital. New! Search Science Daily or the entire web with Google: |
Health Videos & Features
Preparing for the Role of Caregiver
 When a frail or chronically ill loved one can longer care for him or herself the issue confronting families is what to do about care. There are many options that include nursing home care, assisted living facility, independent living facility and homecare. However, when Medicare does not pay for long-term care at home, families call on the help of long-term care planners who can help someone who is suffering from a physical or mental illness.
Related News SectionsRelated News Topics> more ...
Related Science Stories> more ...
Related Encyclopedia Articles> more ...
Related Book ReviewsRole Of Anesthetics In Alzheimer's Disease: Molecular Details Revealed (January 25, 2007) -- Inhaled anesthetics commonly used in surgery are more likely to cause the aggregation of Alzheimer percents disease-related plaques in the brain than intravenous anesthetics say University of ... > full story MGH Researchers Connect Alzheimer's Mutations To Cell-Death Process (July 17, 1997) -- Researchers at the Massachusetts General Hospital have discovered that two genes associated with early-onset Alzheimer's disease are involved in programmed cell death. They also showed that an ... > full story Researchers Identify Brain Protein That Halts Progression Of Alzheimer's (October 25, 2004) -- Researchers have identified a protein in the brain that halts the progression of Alzheimer's disease in human brain tissue. The protein, known as "transthyretin," protects brain cells from gradual ... > full story
University Of Kentucky Chandler Medical Center Researchers Identify Protein That May Cause Nerve Cell Death In Alzheimer's Disease (August 14, 1998) -- A team of University of Kentucky Chandler Medical Center researchers has recently discovered that Par-4, a protein, may lead to nerve cell death in Alzheimer's disease and related brain disorders. ... > full story Tau Protein Required For Development Of Alzheimer's Disease (May 7, 2002) -- A group of Northwestern University neuroscientists have reported the first evidence showing that tau must be present to enable beta-amyloid to induce the degeneration of brain cells that occurs in ... > full story A Synthetic Peptide Destroys Brain Plaque Implicated In Alzheimer's Disease (July 2, 1998) -- New York University School of Medicine researchers have created a protein fragment that blocks the formation of a substance implicated in causing Alzheimer's disease, a finding that may lay the ... > full story Toxic Protein That Interferes With Brain Signals May Trigger Onset Of Alzheimer's Disease (May 28, 1998) -- Researchers have discovered new, highly toxic proteins that disrupt brain mechanisms for learning and memory and which may set off the progression of Alzheimer's disease. ... > full story Plaque-Forming Protein Seen In Alzheimer's Linked To Clogged Brain Transportation System (December 6, 2001) -- A protein linked to accumulation of harmful brain plaque in Alzheimer's patients has been shown in fruit flies and mice to be an important part of a molecular transportation system that moves signals ... > full story In New Alzheimer's Studies, Lab Tests Show Vitamin E And Other Antioxidants Preventing Brain Cell Death (August 28, 1998) -- In laboratory tests, vitamin E prevented the death of brain cells exposed to a toxic protein found in the brains of patients with Alzheimer's disease, it was reported here today (Aug. 27). The ... > full story Amyloid -- Amyloid describes various types of protein aggregations that share specific traits when examined microscopically. For a period, the scientific community debated whether or not amyloid deposits were ... > full article Dementia with Lewy bodies -- Dementia with Lewy bodies is the second most frequent cause of hospitalization for dementia, after Alzheimer's disease. Current estimates are that about 60 to 75% of diagnosed dementias are of the ... > full article Huntington's disease -- The causative gene for Huntington's disease, HD, one of the first genes identified to cause an inherited disease, is located on chromosome 4. Huntington's disease is inherited in an autosomal ... > full article Alzheimer's disease -- Alzheimer's disease (AD), a neurodegenerative disease, is the most common cause of dementia and characterized clinically by progressive intellectual deterioration together with declining activities ... > full article Penicillin-like antibiotics -- Beta-lactam antibiotics are a broad class of antibiotics which include penicillin derivatives, cephalosporins, monobactams, carbapenems and Beta-lactamase inhibitors; basically any antibiotic agent ... > full article Local anesthetic -- A local anesthetic is a drug that reversibly inhibits the propagation of signals along nerves. When it is used on specific nerve pathways, effects such as analgesia (loss of pain sensation) and ... > full article Prion -- A prion (short for proteinaceous infectious particle) is a unique type of infectious agent, as it is made only of protein. It is now commonly accepted that prions are responsible for a number of ... > full article Ketone bodies -- Ketone bodies are three chemicals that are produced as by-products when fatty acids are broken down for energy. Contrary to what the name "bodies" may suggest, these are soluble compounds, not ... > full article Excitotoxicity and cell damage -- Excitotoxicity is the pathological process by which neurons are damaged and killed by the overactivations of receptors for the excitatory neurotransmitter glutamate, such as the NMDA receptor and ... > full article Keratin -- Keratins are a family of fibrous structural proteins; tough and insoluble, they form the hard but nonmineralized structures found in reptiles, birds and ... > full article
|
||||||||||||||||||||
